Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 23:16:27.
doi: 10.1186/s12906-016-1002-7.

Wen-Xin Decoction ameliorates vascular endothelium dysfunction via the PI3K/AKT/eNOS pathway in experimental atherosclerosis in rats

Affiliations

Wen-Xin Decoction ameliorates vascular endothelium dysfunction via the PI3K/AKT/eNOS pathway in experimental atherosclerosis in rats

Tongda Li et al. BMC Complement Altern Med. .

Abstract

Background: Nitric oxide (NO) is the most powerful vasodilator that inhibits leukocyte adhesion, platelet aggregation, and vascular smooth muscle cell proliferation. However, excessive NO can cause lipid peroxidation and direct endothelial cell damage. Therefore, investigation of the role of NO in artherosclerosis development is important. Wen-Xin Decoction (WXD) has been shown to relieve myocardial ischemia reperfusion injury and prevent leukocyte adhesion and invasion; in addition, it can accelerate angiogenesis and prevent platelet activation and aggregation. In this study, we focused on the NO pathway to further clarify the protective effects of WXD on the vascular endothelium in rat models of artherosclerosis.

Methods: Wistar rats were randomly divided into a normal group (n = 10) and a model group (n = 75). Rat models of atherosclerosis were generated by intraperitoneal vitamin D3 (3 months) injections and administration of a high-fat diet (3 months with vitamin D3 and 2 months alone). The model rats were randomly divided into five groups (n = 15 each): model (saline), atorvastatin (4.8 mg/kg/d atorvastatin), high-dose WXD (9 g/kg/d), medium-dose WXD (4.5 g/kg/d), and low-dose WXD (2.25 g/kg/d) groups. Each group received continuous drug or saline administration (suspended liquid gavage) for 30 days, following which all animals were sacrificed. The ultrastructure and histopathological changes of vascular endothelial cells and the expression of PI3K/AKT/eNOS and iNOS in the thoracic aorta tissue were analyzed.

Results: WXD increased NO levels, modulated the NO/ET-1 ratio, and promoted repair of the injured vascular endothelium in a dose-dependent manner. At a high dose, WXD regulated the NO/ET-1 ratio as effectively as atorvastatin; furthermore, it increased NO levels within the physiological range to prevent endothelial damage caused by excessive NO expression. Real-time polymerase chain reaction and Western blot analysis showed that WXD significantly upregulated the mRNA and protein expressions of PI3K, AKT, and eNOS mRNA and significantly increased AKT and eNOS phosphorylation.

Conclusions: Our results suggest that WXD protects and maintains the integrity of the vascular endothelium by activating the PI3K/AKT/eNOS pathway, decreasing iNOS expression, and promoting the release of physiological NO levels.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Changes in the structure and ultrastructure of the aortic arch as observed by transmission electron microscopy (magnification, ×10,000) after 30 days of treatment with Wen-Xin Decoction (WXD). a normal group; b model group; c low-dose WXD group; d medium-dose WXD group; e high-dose WXD group; f atorvastatin group
Fig. 2
Fig. 2
Effects of Wen-Xin Decoction (WXD) on histopathological changes in the aortic arch after 30 days of treatment (magnification, ×200). a normal group; b model group; c low-dose WXD group; d medium-dose WXD group; e high-dose WXD group; f atorvastatin group
Fig. 3
Fig. 3
a Effects of Wen-Xin Decoction (WXD) on serum nitric oxide (NO) levels. b Effects of WXD on the serum NO/ET-1 ratio (n = 10)
Fig. 4
Fig. 4
Protein expression of PI3K, AKT, p-AKT, and β-actin in the aorta after 30 days of Wen-Xin Decoction (WXD) treatment. Data are obtained from six rats. *p < 0.05, **p < 0.01 compared with the normal group. # p < 0.05, ## p < 0.01 compared with the model group, p < 0.05 compared with the atorvastatin group
Fig. 5
Fig. 5
Protein expression of eNOS, p-eNOS, iNOS, and β-actin in the aorta after 30 days of Wen-Xin Decoction (WXD) treatment. Data are obtained from six rats. *p < 0.05, **p < 0.01 compared with the normal group. # p < 0.05, ## p < 0.01 compared with the model group
Fig. 6
Fig. 6
Fold-changes in the expression of PI3K, AKT, eNOS, and iNOS mRNA in the thoracic aorta, measured by real-time polymerase chain reaction (PCR) and calculated by the 2−∆∆CT method, after treatment with various doses of Wen-Xin Decoction (WXD) for 30 days. Data are obtained from six rats. *p < 0.05 compared with the normal group. # p < 0.05 compared with the model group

References

    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3 doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
    1. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts) N Engl J Med. 1976;295:369–77. doi: 10.1056/NEJM197608122950707. - DOI - PubMed
    1. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–26. doi: 10.1056/NEJM199901143400207. - DOI - PubMed
    1. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, et al. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol. 2002;136:773–83. doi: 10.1038/sj.bjp.0704778. - DOI - PMC - PubMed
    1. Williams B. Angiotensin II, and the pathophysiology of cardiovascular remodeling. Am J Cardiol. 2001;87:10C–7. doi: 10.1016/S0002-9149(01)01507-7. - DOI - PubMed

Publication types

MeSH terms